Highlights AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
6.52 ^USD	+0.31%		+3.99%	-16.84%

May. 21	AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System	MT
May. 06	AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV)	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System	May. 21	MT
AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV)	May. 06	CI
AngioDynamics Shares Jump After Fiscal Q3 Results, FDA Clearance For Device	Apr. 04	MT
AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System	Apr. 04	DJ
Earnings Flash (ANGO) ANGIODYNAMICS Reports Q3 Revenue $66M	Apr. 04	MT
AngioDynamics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	Apr. 04	CI
AngioDynamics, Inc. Reports Consolidated Goodwill Impairment for Third Quarter Ended February 29, 2024	Apr. 04	CI
AngioDynamics, Inc. Provides Sales Guidance for the Fiscal Year 2024	Apr. 04	CI
AngioDynamics, Inc. Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE	Apr. 04	CI
AngioDynamics Settles Patent Dispute with Becton, Dickinson Affiliate	Apr. 01	MT
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co	Apr. 01	DJ
AngioDynamics Sells Two Product Lines to Spectrum Vascular for up to $45 Million Cash; Shares Up in Pre-Bell Trading	Feb. 16	MT
Spectrum Vascular acquired PICC and Midline Product Portfolios from AngioDynamics, Inc. for $45 million.	Feb. 14	CI
AngioDynamics Receives FDA Clearance for Auryon XL Radial Access Catheter	Jan. 23	MT
Angiodynamics Announces FDA 510(K) Clearance of Auryon Xl Radial Access Catheter to Treat Peripheral Arterial Disease	Jan. 23	CI
AngioDynamics Shares Fall After Q2 Swing to Adjusted Loss; Revenue Drops	Jan. 05	MT
AngioDynamics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	Jan. 05	CI
AngioDynamics, Inc. Announces Manufacturing Operations Restructuring	Jan. 05	CI
AngioDynamics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Jan. 05	CI
AngioDynamics, Inc. Completes Patient Enrollment in Apex-Av Study Assessing Alphavac F1885 System in Treatment of Pulmonary Embolism	Dec. 07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Highlights

Filters